Metagenomic libraries are gene libraries constructed from total DNA directly isolated from an environmental source rather than laboratory cultures. The key advantage of these libraries is that they allow the access to unknown environmental genetic resources independently of our ability to cultivate the microorganisms encoding them. Metagenomic libraries can be analyzed by systematically sequencing all the genomic clones obtained, or by functionally screening clones for novel phenotypes conveyed to host bacteria from metagenomic sequences.

Sequence-based gene identification relies on similarities to known gene sequences, while functional screening approaches have the advantage of being able to identify genes whose functions cannot be predicted by sequence analysis alone. However, a significant limitation of functional screening is that detection depends on efficient expression of the cloned genes. In fact, it has been shown that most genes are not usually expressed in the selected host bacterium[@b1][@b2]. Although some novel activities have been detected using *E. coli* as the surrogate host, increasing the efficiency of metagenomic gene expression in the bacterial hosts could greatly improve our ability to detect metagenomic clones encoding genes with novel functions.

Once environmental DNA samples (metagenomic DNA) are cloned into multicopy expression vectors, their expression can be driven in heterologus systems using promoters adjacent to the cloning site. However, the ability to efficiently drive metagenomic gene expression inversely correlates with the size of the cloned DNA. A major limiting factor is the presence of transcription terminators upstream the gene of interest. High hit rates have been reported for metagenomic libraries with heterologous promoters and very short DNA fragments of 1--3 Kb long[@b3][@b4][@b5]. However, reducing the size of the cloned DNA fragments implies a lower probability of having a gene of interest in a given clone and, therefore, a higher number of metagenomic clones are required to cover the same length of total metagenomic DNA. The use of small clones may be successful in identifying activities that are selectable and depend on expression of a single gene but is unlikely to be suitable for non-selectable activities given the large number of metagenomic clones that would need to be screened.

In order to overcome the inherent limitation of expressing genes in *E. coli*, the most frequent surrogate host for metagenomic libraries, a number of shuttle or broad host range vectors have been constructed with differing degrees of success in allowing the transfer and screening of the metagenomic library to different host bacteria[@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b13]. Functional screening of metagenomic libraries using these vectors have shown that different positive clones can be obtained depending on the host bacteria used for the screening[@b14]. Although many of these methods represent an improvement, the expression of metagenomic genes still relies on their own expression capacity within the surrogate host.

In this work, we used an alternative approach to increase the potential of functional metagenomic analysis. We report on the construction of specialized vectors and strains, which combine the use of *E. coli* as the surrogate host with two modified heterologous expression systems that incorporate viral components. One is based on the phage T7 RNA-polymerase that is insensitive to many of the bacterial transcription termination signals[@b15][@b16]. The other expression method involves the use of the N anti-termination protein from the *λ* phage[@b17] coupled to a positively controlled bacterial regulatory system inducible by salicylate[@b18].

Results
=======

Construction of metagenomic vectors
-----------------------------------

In order to improve performance of the pCC1FOS cloning vector, we modified it in three different ways: 1) insertion of an *oriT* to allow transfer of the metagenomic library by conjugation, 2) the addition of a transcription system subject to anti-termination to improve metagenomic gene expression, and 3) incorporation of a promoterless *gfp* gene to allow detection of metagenomic gene expression.

We started from a previous modification of the pCC1FOS fosmid vector (Epicentre), consisting of the insertion of two *Ceu*I sites flanking the metagenomic DNA cloning site (*Eco*72I) (M. Ferrer, personal communication).

The *oriT* from plasmid RP4 was cloned into the unique *Hpa*I site of pCC1FOS-CeuI, thus generating pMPO561, to allow transfer by conjugation in triparental matings[@b19]. Next, a DNA fragment containing the *psaI* promoter regulatory sequence, the *nahGHILNJK* operon promoter and the lambda phage *nut~L~* site (N-utilization leftward site) was synthesized and cloned just upstream of the T7 gene 10 already present in pCC11FOS, to yield pMPO571 ([Fig. 1](#f1){ref-type="fig"}). The *nahGHILNJK* operon is involved in naphthalene biodegradation and is activated by NahR in response to salicylate[@b18][@b20][@b21]. The *nut~L~* site (N-utilization leftward site) allows the phage transcription anti-termination protein N to assemble with the transcription complex, thus making it insensitive to transcription termination signals[@b22][@b23]. This vector should allow transcription of cloned metagenomic DNA by two distinct RNA polymerases: (i) the T7 RNA polymerase, from the T7 gene 10 promoter, and (ii) the bacterial RNA polymerase modified for processive anti-termination by the lambda phage N protein, from the p*sal* promoter.

An additional modification of pMPO571 to yield pMPO579 involved cloning a promoterless *gfp* gene with a strong ribosome binding site from the T7 gene 10, downstream of the vector promoters and the metagenomic DNA cloning site ([Fig. 1](#f1){ref-type="fig"}). Metagenomic DNA transcription in the appropriate direction can result in transcription continuing through to this promoterless *gfp* gene. This allows for the exploitation of Substrate Induced Gene Expression (SIGEX) technology[@b24] to identify regulatory systems, by detecting GFP fluorescence as an indication of active transcription of the fosmid clones and sorting the appropriate clones by fluorescence assisted cell sorting (FACS). For pMPO571 and pMPO579 construction details, see [supplementary Methods](#s1){ref-type="supplementary-material"}.

Construction of specialized strains for metagenomic DNA transcription
---------------------------------------------------------------------

The MPO553 strain is a EPI300-T1 derivative, with the *lac*UV5 promoter, the attenuator *nasF* and the gene-1 of the T7 phage, coding for the T7 RNA polymerase, inserted into its *trg* locus ([Fig. 2](#f2){ref-type="fig"}. For MPO553 construction details, see [supplementary Methods](#s1){ref-type="supplementary-material"}). In the absence of the lacI repressor, such as in EPI300-T1, the *lac*UV5 promoter constitutively drives gene-1 transcription. The *nasF* attenuator is a transcription terminator signal within the nitrate assimilatory *nasFEDCBA* operon, subjected to transcriptional attenuation[@b25], which has been used very successfully to reduce expression vector transcription levels[@b26][@b27]. Therefore, this strain should produce constitutive but low levels of T7 RNA polymerase.

The MPO554 strain has an insertion in *trg* containing the activator *nahR* gene and the p*sal* promoter followed by the lambda gene N ([Fig. 2](#f2){ref-type="fig"}. For MPO554 construction details, see [supplementary Methods](#s1){ref-type="supplementary-material"}). Upon induction with salicylate, NahR would activate p*sal* in the fosmid vector, thus activating transcription of the metagenomic DNA, and simultaneously p*sal* in the bacterially-inserted construction, thus activating N protein-dependent processive antitermination e at transcripts initiated from p*sal* in the vector. MPO555 is a strain essentially the same as MPO554 but with a frameshift in the gene N.

Functionality tests of the vectors and specialized strains
----------------------------------------------------------

Triparental matings were prepared in which EPI300-T1 carrying different plasmids were used as donors, rifampicin resistant (Rif^R^) or nalidixic acid resistant (Nal^R^) derivatives of EPI300-T1 were used as recipients, and DH5α bearing pRK2013 used as the helper strain. pCC1FOS-CeuI could not be transferred by conjugation (mating frequency \<10^−7^). However, pMPO579 was transferred to all the recipient strains with frequencies above 10%, representing similar or higher frequencies to those obtained with the well-known mobilizable plasmid pBBR1MCS-3 (not shown).

Transcription levels from the heterologous promoters present in the modified vectors were tested in pMPO579, which contains the promoterless *gfp* reporter gene downstream of the metagenomic cloning site. To test whether transcription initiated at the heterologous promoters could proceed through transcription terminators, a 2.5 Kb DNA fragment bearing the *thnL* transcription terminator from *Sphingomonas macrogolitabida* strain TFA[@b28] was cloned into the *Eco*72I site of pMPO579 to generate pMPO580.

Fluorescence of the EPI300-T1/pMPO579 strain was low (about 1,300 F.U., similar to the intrinsic fluorescence of EPI300-T1^R^). The addition of arabinose and salicylate resulted in a small increase in GFP expression ([Fig. 3](#f3){ref-type="fig"}). In the specialized strain that produces the transcriptional activator NahR but not the antitermination protein N (MPO555), the basal level of *gfp* expression from pMPO579 was also low. Increasing the plasmid copy number by adding arabinose resulted in a modest increase in expression levels, but much higher levels of expression were obtained when both arabinose and salicylate were added to the culture medium together ([Fig. 3](#f3){ref-type="fig"}). This shows that p*sal* in pMPO579 is functional and that MPO555 produces the required transcriptional activator NahR. In contrast, when using pMPO580, which bears the *thnL* terminator, induction in the presence of arabinose and salicylate, was almost negligible, demonstrating that the transcription terminator was functional. Interestingly, *gfp* transcription from pMPO580 in MPO554, which expresses both NahR and N genes, was almost as high as that obtained with pMPO579. Taken together, these results indicate that transcription from *psal* in pMPO580 is terminated at the *thnL* terminator before reaching the *gfp* gene, but that transcription can continue onto the *gfp* gene if production of the anti-termination protein is also induced by salicylate.

In the MPO553 strain, which constitutively produces low levels of T7 RNA-polymerase, expression levels were very low in the absence of arabinose ([Fig. 4](#f4){ref-type="fig"}). However, GFP expression dramatically increased to even higher levels than those obtained from the p*sal* promoter when the plasmid copy number was increased by addition of arabinose. This clearly shows that the T7 promoter in pMPO579 is functional and that the specialized MPO553 strain produces T7 RNA-polymerase. The *gfp* expression level from the plasmid pMPO580, which contains the *thnL* terminator, was higher than that from pMPO579, indicating that this terminator does not terminate transcription by the T7 RNA-polymerase.

A reconstruction of the SIGEX technology[@b24] was performed by mixing cultures of MPO554 Rif^R^ and MPO554 Nal^R^ carrying the plasmid pMPO579. Only the MPO554 Nal^R^/pMPO579 culture was pre-induced with salicylate to transcribe *gfp* from the standard p*sal* catabolic promoter. Cultures were mixed in the 1:1, 1:10 and 10:1 ratios of Nal^R^:Rif^R^, purified by FACS and plated for subsequent resistance analysis to establish the ratios of induced *vs*. non-induced bacteria recovered after sorting. At the 1:1 Nal^R^:Rif^R^ ratio, all the bacteria recovered after sorting were Nal^R^ (induced); at the 1:10 Nal^R^:Rif^R^ ratio, the proportion of induced bacteria increased from 0.01% to approximately 30% after sorting; finally, at the 1:10 Nal^R^:Rif^R^ ratio this proportion increased from 0.001% to approximately 15% after sorting. Thus, FACS enriched the induced strain 10^4^-fold.

Construction of a metagenomic library and identification of clones conferring carbenicillin resistance
------------------------------------------------------------------------------------------------------

The plasmid pMPO579 was used to construct a metagenomic library from a shore at Punta San García, Cádiz, Spain contaminated with crude oil from a tanker spill. The library comprises approximately 2 Gigabases distributed across approximately 54,000 different clones, and is maintained in the strain EPI300-T1.

Resistance to β-lactams are predicted to be abundant in soils even in the absence of anthropogenic selection pressure[@b29][@b30]. Because of this and because it is easily selectable, resistance to carbenicillin was chosen as the activity of interest to be identified in the transferred metagenomic clones.

Direct selection of the EPI300-T1 culture hosting the library for carbenicillin-resistant clones resulted in the isolation of just a few tiny colonies after 2 days of incubation with a frequency much lower than 1/54,000. This indicated that none of the fosmids was efficiently conferring resistance to Cb100 to EPI300.

Triparental matings were performed using the EPI300-T1 hosting the bulk metagenomic library as the donor culture, each of the nalidixic acid derivatives from EPI300-T1, MPO553 and MPO554 as recipient strains, and DH5α/pRK2013 as the helper strain. We observed a very high conjugation frequency of over 6%, regardless the recipient strain. This indicates that the original pMPO579 vector and the metagenomic clones can be transferred to other strains with similar efficiency, despite the approximately 40 Kb of metagenomic DNA that each clone is expected to carry.

An approximately 6-fold increase in transconjugants resistant to 100 mg L^−1^ carbenicillin (Cb^R^) were obtained with the specialized strains (6×10^−5^ positives/transconjugants) versus the conventional EPI300-T1 NalR strain. In the case of the MPO554 strain, this increase was dependent on the addition of salicylate, which induces transcription activation from *psal* by NahR and anti-termination by the N protein (not shown).

A total of 6 different fosmids were isolated from the 100 transconjugants derived from NalR derivatives of EPI300-T1, MPO553 or MPO554. All EPI300-T1 Cb^R^ transconjugants contained the same fosmid, whose restriction pattern matched that previously identified in the clone directly selected from the library. This fosmid, designated ETN1, was also found after the direct selection of carbenicillin resistant clones from the culture hosting the original library, and among the transconjugants derived from the specialized strains. The use of the strain producing T7 RNA polymerase allowed identification of 3 additional fosmids, TN2, TN3 and TN4. These fosmids were also identified among the transconjugants derived from MPO554, the specialized strain bearing the N anti-termination system. This strain allowed identification of 2 additional fosmids, N5 and N6, which were not detected using the other strains.

To confirm the capacity of each fosmid to confer Cb^R^ to each of the recipient strains, the six fosmids were transferred back to the EPI300-T1 Rif^R^ derivative and the resulting strains were used as donors in triparental matings together with the Nal^R^ derivatives as recipient strains and the DH5α/pRK2013 helper strain. As shown in [Table 1](#t1){ref-type="table"}, only the fosmid ETN1 conferred Cb^R^ to EPI300-T1 Rif^R^. In addition, the carbenicillin resistance provided by this fosmid was apparently limited since only one tenth of the transconjugants exhibited sufficient resistance to generate a colony on LB-agar containing carbenicillin. The fosmids ETN1, TN2, TN3 and TN4 provided Cb^R^ to the strain MPO553 that produces T7 RNA-polymerase, and all 6 fosmids conferred Cb^R^ to the strain MPO554. These results using the isolated fosmids are in full agreement with those obtained using the bulk metagenomic library and confirm that at least six fosmids of the library potentially encode carbenicillin resistance genes. However, only a small fraction (one out of six) of the fosmids actually expressed the resistance gene by itself and conferred Cb^R^ in the EPI300-T1 strain.

Gene identification in fosmids providing carbenicillin resistance
-----------------------------------------------------------------

Sequence analysis of each fosmid revealed a number of genes that may confer resistance to carbenicillin, whose locations and orientations are shown in [Figure 5](#f5){ref-type="fig"}.

ETN1 encodes a class-C β-lactamase that is oriented opposite to the heterologous promoters. This β-lactamase is most similar to homologues found in different *Pseudomonas* species*.* Immediately downstream of the *blaC* gene is a 103 amino acid open reading frame containing a 4 nucleotide overlap with the *blaC* 3′end. The overlap may be indicative of translational coupling, suggesting that the short Orf could be related to the β-lactamase function. The *blaC* gene either with or without the short *orf* was subcloned into pMPO579 in the same orientation as the heterologous promoters. Although more tolerant than the strain without the plasmid, most of the transconjugants receiving any of these subclones were unable to produce a colony in the presence of Cb~100~, which indicated that the *blaC* alone cannot account for all the carbenicillin resistance provided by the original fosmid.

ETN1 also codes for the 3 components of an efflux pump of the resistance-nodulation-cell division (RND) permease family. The fosmid also contains a fourth component encoding an additional outer membrane protein. Since efflux pumps have been shown to contribute to the tolerance of bacteria to different toxic compounds such as aromatic compounds or antibiotics[@b31], this efflux pump could also contribute to the carbenicillin resistance.

In the TN2 fosmid a class-B β-lactamase gene was found 6 Kb downstream of the heterologous promoters in the same orientation and a *blaR* gene encoding a LysR-type transcriptional activator just upstream in the opposite direction. The remaining sequence codes for hypothetical proteins or proteins with unrelated functions. In spite of *blaR*, this *blaB* gene could not be autonomously expressed in *E. coli*, though it was transcribed from any of the heterologous promoters present in the vector.

TN3 and TN4 have largely common inserts. In fact, the TN4 insert is included within the insert of TN3. Neither of these fosmids contain Orfs putatively coding for a β-lactamase enzyme. The only genes potentially involved in Cb resistance in these fosmids code for the components of an RND-type efflux pump that are located in the same orientation 16 Kb or 13 Kb from the heterologous promoters, depending on the fosmid. A DNA fragment encoding just the 3 components of the efflux pump was subcloned from TN4 into the pMPO579 vector in the appropriate orientation and the resulting plasmid, pMPO586, transferred to MPO554. The subclone was able to provide resistance to Cb~100~ although only when salicylate is present, just as with the original fosmid. This indicates that this efflux pump is able to provide carbenicillin resistance by itself if adequately expressed from a heterologous promoter in *E. coli*.

N5 and N6 also share most of their insert DNA, which is cloned in opposite orientations in each fosmid. In N6, a class-B β-lactamase gene was found 11 Kb downstream from the heterologous promoters and transcribed in the same orientation. Presumably, autonomous expression of this gene is not efficient enough, and requires heterologous transcription from the p*sal* promoter to provide full resistance to Cb~100~ in *E. coli*. Intriguingly, in N5 this gene is located in the opposite orientation but N5 also requires salicylate induction to confer carbenicillin resistance. A possible explanation is that heterologous transcription in N5 results in expression of a gene coding for an activator of the *blaB* gene. A candidate activator gene, located 27 Kb away from the p*sal* promoter is shown in [Fig. 5](#f5){ref-type="fig"}. Alternatively, some additional open reading frames in the same orientation as p*sal* could be responsible for carbenicillin resistance in N5. There are 5 other *orfs* in the same orientation as p*sal* but none of the predicted amino acid sequences provide any clue regarding their potential function.

Discussion
==========

Functional metagenomic technology is a powerful tool that has been applied to the discovery of novel natural products and enzymes of biotechnological interest[@b32]. The potential of functional metagenomics has been hampered by inefficient metagenomic gene expression in heterologous hosts. Although gene expression is a multi-step process involving transcription, translation and post-translational modifications, transcription is the most frequently regulated process and is probably the main limiting step of metagenomic gene expression in surrogate hosts. Because of that, the aim of this work was to improve metagenomic gene transcription. Here we have shown that heterologous gene transcription is an effective way of increasing the efficiency of metagenomic gene expression provided that transcription can proceed along the metagenomic DNA. To prevent transcription termination at metagenomic termination signals, we have taken advantage of two phage expression systems that are much less sensitive to the bacterial transcription termination signals.

The N anti-termination system is inducible allowing metagenomic gene expression to be regulated. In addition, absolute expression levels can be modulated since salicylate-inducible system drives different expression levels in proportion to the salicylate concentration[@b33]. This feature may be of particular relevance when expressing functions that might be deleterious to the surrogate host[@b34].

On the other hand, the T7 expression system constructed in the strain MPO553 is constitutive, although polymerase expression levels are kept low by the *nasF* attenuator inserted between the *lac*UV5p and the gene-1. Expression levels from the T7 promoter are still 3-fold higher than those obtained from the p*sal* promoter. However, in the case that overexpression of the screened function has a deleterious effect on bacterial growth, expression can be reduced by not increasing the plasmid copy number ([Fig. 4](#f4){ref-type="fig"}).

The metagenomic library constructed with DNA from a contaminated coastal soil resulted in 54,000 independent clones. Although, metagenomic libraries with higher number of clones have been reported using the original vector, the number of clones depends on the quality of the DNA samples and, although we did not test whether during pCC1-FOS modifications we had inadvertently altered the *cos* site of the vector, we did not alter this sequence and, a priori, there is no reason to think that the modified vector had lower packaging efficiency than the the original vector. Testing heterologous gene expression involved transferring the metagenomic library by mating to the specialized strains. This way, a total of 6 clones conferring carbenicillin resistance were isolated from a metagenomic library containing 2 Gb of metagenomic DNA. Although this ratio of positive clones may look low, it is comparable to those obtained with other metagenomic libraries[@b5][@b30]. In addition, the diversity and abundance of antibiotic resistance determinants can also be very different depending on the DNA source. It is important to bear in mind that our metagenomic DNA comes from a soil contaminated by an oil spill, and therefore the biodiversity and relative abundance of antibiotic resistance genes may be lower than that of a non-contaminated soil. Theoretically, this additional mating step might impose some bias against fosmids that in some way reduce the growth rate of the bacterial host, thereby reducing the recovered diversity after the mating. However, at least in the case of carbenicillin resistance determinants, this additional step did not prevent the isolation of the fosmid already identified by direct selection using the original library, but rather increased recovered diversity since it allowed the identification of 5 additional fosmids. In any case, in order to prevent this potential bias, it is possible to directly construct the metagenomic library using a specialized strain such as MPO554 as the surrogate host.

Although the N anti-termination system allowed identification of some fosmids that the T7 expression system could not, both systems allowed metagenomic gene transcription from promoters located at least 16 Kb upstream, and through a number of genes in the opposite orientation to the promoter (see fosmid TN3). Although other factors may influence gene expression levels and may preclude identification of other positive clones present in the metagenomic library, it is clear that transcription is a major limiting factor for the functional analyses of metagenomic libraries, which can be circumvented by the phage-based heterologous expression systems.

The vector also includes a promoterless *gfp* downstream of the metagenomic cloning site to exploit the SIGEX technology, which has considerable potential for the identification of inducible genes and regulatory systems. In spite of the potential problems that may prevent the identification of a regulatory system by using this type of screen[@b35], there are ways of avoiding them[@b36]. Our reconstruction of SIGEX technology indicates that a bacterial subpopulation expressing genes from a conventional catabolic promoter such as p*sal* can be detected and enriched 10^4^-fold by FACS. This enrichment is sufficiently high to detect positive clones that were present in a metagenomic library with a frequency of 10^−6^ or even lower, therefore, enough to detect any positive clone that is present in a metagenomic library.

Besides the relatively low permeability of the outer membrane of gram negative bacteria, there are 3 main mechanisms for conferring tolerance to β-lactam antibiotics[@b37]. Among the resistant clones we have found genes coding for β-lactamases and for efflux pumps ([Fig. 5](#f5){ref-type="fig"}) but not penicillin binding proteins (insensitive transpeptidases). Of the efflux pumps, those belonging to the RND (Resistance-Nodulation-Division) are the only ones that exist in a tripartite form traversing both the outer and inner membrane and can pump molecules from the cytoplasm, from the periplasm or even when associated to the inner membrane[@b31]. Although many RND pumps can accommodate β-lactams, just a few have been definitely linked to β-lactam resistance[@b38]. They are usually associated to other forms of resistance such as a β-lactamase although beta-lactamase-negative, ampicillin-resistant (BLNAR) *Haemophilus influenza* isolates have been described that can tolerate up to 16 mg L^−1^ of ampicillin[@b39]. In these cases, overexpression of the AcrAB efflux pump was associated with mutations in PBP3, one of the 5 penicillin binding proteins of *H. influenzae*, that lowered affinities of beta-lactams to PBP3. Previous metagenomic analyses of β-lactam resistance resulted in large numbers of clones bearing *bla* genes but no efflux pumps have previously been linked to *bla* genes or to beta-lactam resistance[@b40].

The way earlier metagenomic libraries were constructed may have prevented the identification of other resistance determinants in the past given that we have shown that some metagenomic RND pumps are not only contributing to carbenicillin resistance but are able to confer *E. coli* resistance to 100 mg L^−1^ of carbenicillin by themselves (fosmids TN3 and TN4).

Methods
=======

Bacterial strains, growth conditions, plasmids and oligonucleotides
-------------------------------------------------------------------

The bacterial strains and plasmids used in this study are described in [Table 2](#t2){ref-type="table"}. Luria-Bertani (LB) medium or LB-agar was used as the standard growth medium, and bacteria were grown at 37°C except for the screening and selection of fosmids conferring carbenicillin resistance that were carried out at 30°C. When needed, antibiotics were used at the following concentrations: 12.5 μg mL^−1^ chloramphenicol, 100 μg mL^−1^ carbenicillin, 15 μg mL^−1^ nalidixic acid, 20 μg mL^−1^ rifampicin, 25 μg mL^−1^ kanamycin and 100 μg mL^−1^ ampicillin. The copy number of the fosmids in EPI300™-T1 and derivative strains was increased by the addition of 1 mM arabinose. 5 mM salicylate was used as an inducer for transcription level analyses and 1 mM salicylate for the screens.

DNA manipulations were performed according to standard procedures[@b41]. Details on the construction of fosmids and strains in this work are described in [Supplementary Methods](#s1){ref-type="supplementary-material"}.

Oligonucleotides are described in [Supplementary Table S1](#s1){ref-type="supplementary-material"}.

Conjugative matings
-------------------

Vectors and metagenomic libraries were transferred by triparental matings[@b19] with DH5α/pRK2013 as the helper strain. Conjugative matings were performed on LB-agar without antibiotic selection overnight at 30°C. The mating mixtures were then plated on LB-agar with the necessary antibiotics for the transconjugants selection, carbenicillin for the screening and arabinose for increasing the copy number of the fosmid, and incubated at 30°C for 48 h.

Mating frequencies were estimated as the ratio of transconjugant clones of the recipient strain (chloramphenicol+rifampicin resistant or chloramphenicol+nalidixic acid resistant clones) to total clones of the recipient strain (either rifampicin or nalidixic acid resistant, depending on the recipient strain).

Functionality tests of the vectors and specialized strains
----------------------------------------------------------

The transcription levels from the heterologous promoters present in the modified vectors were analysed by detecting the fluorescence levels from the promoterless *gfp* gene, which is used as a reporter gene. Analyses were performed in the multifunctional microplate reader POLARstar Omega (BMG LABTECH GmbH, Germany), with a microplate COSTAL 96 and the following parameters: excitation filter 485BP1, emission filter EM520 and gain 1000.

Flow cytometry and sorting
--------------------------

Mixed bacterial cell suspensions were analyzed by flow cytometry using a FACScalibur cytometer equipped with an argon laser emitting at 488 nm. Bacteria were detected by side scatter (488/10 nm band pass filter) and the fluorescence intensity was detected using the FL1 channel (530/30 nm band pass filter). The Cellquest Pro software (Becton-Dickinson) was used for data acquisition and analysis. For cell sorting, flow cytometer water lines were pre-treated with a bleach solution (FACSClean) and autoclaved phosphate saline buffer (PBS) was used as sheath fluid. The exclusion mode was used to sort GFP-expressing cells. Sorting gates were sufficiently separated to avoid false positives/negatives.

Construction of a metagenomic library
-------------------------------------

Bacteria were extracted by direct addition of 400 mL of disruption buffer (0.2 M NaCl, 50 mM Tris-HCl pH 8.0) to 160 g of the soil sample and mixing overnight with shaking. The suspension was centrifuged at low speed (400 g for 3 minutes) and the supernatant poured over 10 mL of a Nycodenz resin solution (1.3 g mL^−1^). Centrifugation in a gradient of the Nycodenz resin (Axis-Shield) was carried out at 10,000 *g* × for 40 minutes at 4°C. The bacteria-containing a band at the interface between the Nycodenz and the aqueous layer were recovered and mixed with PBS. The cells were pelleted by centrifugation at 10,000 g for 20 minutes, and re-suspended in TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). DNA was then extracted with the G NOME DNA kit (MP Biomedicals). Using this method, we obtained 24 μg of DNA from 160 g of soil, with an average size of approximately 40 kb.

The metagenomic library was constructed according to the CopyControl™ Fosmid Library Production kit protocol (Epicentre), except that pMPO579 was used instead of pCC1FOS. pMPO579 was linearised by restriction with the *Pml*I enzyme (New England Biolabs, isoschizomer of *Eco*72I), dephosphorylated with Shrimp Alkaline Phosphatase (USB) and concentrated to 300 mg L^−1^ with a Centrifugal Filter Device (Microcon, Millipore).

Gene identification in fosmids conferring carbenicillin resistance
------------------------------------------------------------------

Each fosmid was sequenced with a Roche 454 GS FLX Ti sequencer (454 Life Sciences, Branford, CT, USA) at Lifesequencing S.L. (Valencia, Spain). Sequences were assembled using the Newbler GS De Novo Assembler v.2.3 (Roche). The assembled sequences were compared to those in the databases using the Blastx and Blastn programs[@b42]. Those orfs potentially involved in carbenicillin resistance are highlighted in [Figure 5](#f5){ref-type="fig"}.

Author Contributions
====================

L.T.-G. designed and performed most of the experiments and analyzed the results, C.M. designed and performed the experiments to validate SIGEX technology, M.C.L.-M. participated in the construction of fosmids and strains, and E.S. designed the general strategy, supervised the work, analyzed data and wrote the paper. All authors reviewed the manuscript.

Supplementary Material {#s1}
======================

###### Supplementary Information

Supplementary information

**Accession codes:** The metagenomic sequences contained within the fosmids have been deposited at theNational Center for Biotechnology Information database (GenBank) under accession numbers JX406851 (ETN1), JX406852 (TN2), JX406853 (TN3), JX406854 (N5) and JX406855 (N6).
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![Schematic diagram of the fosmids derived from pCC1FOS-*Ceu*I.\
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![Expression of the *gfp* gene from pMPO579 or its derivative bearing the *thnL* terminator pMPO580, in the strain MPO553 that constitutively produces low levels of T7 RNA-polymerase.](srep01107-f4){#f4}

![Schematic diagram showing the clones that confer carbenicillin resistance.\
All putative *orfs* and their orientations are shown although only those putatively involved in carbenicillin resistance are highlighted. Genes are not drawn to scale.](srep01107-f5){#f5}

###### Mating transfer of the carbenicillin resistant fosmids. Values represent the frequency of carbenicillin resistant transconjugants relative to those transconjugants that had received the fosmid

                                 Recipient:                                   
  ----------------------------- ------------ ---------- ---------- ---------- -----
  Donor: EPI300-T1^R^ Rif^R^/       ETN1        0.1        0.07       0.3      0.5
                                    TN2       \<10^−5^     0.05     \<10^−5^    1
                                    TN3       \<10^−5^     0.2      \<10^−5^    1
                                    TN4       \<10^−5^     0.2      \<10^−5^   0.9
                                     N5       \<10^−5^   \<10^−5^     0.2       1
                                     N6       \<10^−5^   \<10^−5^     0.1       1

###### Bacterial strains and plasmids used in this work

  Strain                                                                                             Genotype/Phenotype                                                                               Reference/Source
  ---------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  E. coli EPI300-T1^R^    F^−^ mcrA Δ(*mrr-hsd*RMS*-mcr*BC) (Str^R^) Φ80d*lacZ*ΔM15 Δ*lacX74* *rec*A1 *end*A1 *araD*13*9* Δ(*ara*, *leu*)7697 *galU* *galK* λ^−^ *rpsL* *nupG* *trfA* *ton*A *dhfr*      Epicentre
  E. coli MPO553                                                                   EPI300-T1^R^ Δ*trg*::*P~laUV5~*-*nasF* attenuator-gene1                                                               This work
  E. coli MPO554                                                                       EPI300-T1^R^ Δ*trg*:: *nahR/*P*~sal~*--*gene N*                                                                   This work
  E. coli MPO555                                                                 EPI300-T1^R^ Δ*trg*:: *nahR/*P*~sal~*-- *truncated gene N*                                                              This work
  E. coli DH5α                                          ϕ80d*lacZ*ΔM15 Δ(*lacZYA-argF*)U169 *recA*1 *endA*1 *hsdR*17 (r~k~^--^ m~k~^+^) *supE*44 *thi*-1 *gyrA relA*1                                      [@b43]
                                                                                                                                                                                                              
  Plasmid                                                                                            Genotype/Phenotype                                                                               Reference/Source
  pCC1FOS-CeuI                                                       Cm^R^, pCC1FOS (Epicentre) with two *Ceu*I sites flanking the cloning site *Eco*72I                                                 M. Ferrer
  pMPO27                                                         Ap^R^, expression vector with rrnBT1T2-Pm-*nasF* attenuator::MCS, ColE1 replication origin                                                [@b26]
  pCNB4-S2                                                                               Ap^R^ Km^R^ pUT/mini-Tn*5 nahR/Psal→sylS2*                                                                        [@b44]
  pMPO556                                                                             Ap^R^ *P~lacUV5~* cloned into pBluescript II SK+                                                                   This work
  pMPO557                                                                               Ap^R^, *nasF* attenuator cloned into pMPO556                                                                     This work
  pMPO558                                                                   Ap^R^ Km^R^, kanamycin resistance gene from pKD4 cloned into pMPO557                                                         This work
  pMPO559                                                              Ap^R^ Km^R^ Cm^R^, chloramphenicol resistance gene from pKD3 cloned into pGP1-2                                                   This work
  pMPO561                                                                              Cm^R^, pCC1FOS-CeuI derived fosmid with *oriT*                                                                    This work
  pMPO563                                                                       Ap^R^, *nahR*-*P~nah~*-P*sal* cloned into pBluescript II SK+                                                             This work
  pMPO564                                                                Ap^R^ Cm^R^, chloramphenicol resistance gene from pKD3 cloned into pMPO563                                                      This work
  pMPO565                                                                                  Ap^R^ Cm^R^, gene N cloned into pMPO564                                                                       This work
  pMPO571                                             Cm^R^, pMPO561 derived fosmid with P*~sal~*-*nut~L~* cloned downstream T7 promoter and the cloning site *Eco*72I                                   This work
  pMPO575                                                                     Ap^R^ Cm^R^, pMPO565 derived plasmid with a frameshift in gene N                                                           This work
  pMPO579                                                    Cm^R^, pMPO571 derived fosmid with a promoterless *gfp* cloned downstream the cloning site *Eco*72I                                         This work
  pMPO580                             Cm^R^, pMPO579 derived fosmid with the *thnL* transcription terminator from *Sphingomonas macrogolitabida* strain TFA cloned in the *Eco*72I site                  This work
  pMPO586                                                                          Cm^R^ Cb^R^, efflux pump from TN4 subcloned in pMPO579                                                                This work
  pMPO634                                                                                   Km^R^, plasmid containing *gfp* gene                                                                           [@b45]
  RP4                                                                                   Km^R^ Ap^R^ (Tn1) Tc^R^ IncP-1 Tra^+^ Cma^−^                                                                       [@b46]
  pNK736                                                                                    Ap^R^, plasmid containing P*~lacUV5~*                                                                          [@b47]
  pBluescript II SK+                                                                               Ap^R^, phagemid vector                                                                                Stratagene
  pBluescript II KS+                                                                               Ap^R^, phagemid vector                                                                                Stratagene
  pBBR1MCS-3                                                                                     Tc^R^, mobilisable plasmid                                                                                [@b48]
  pRK2013                                                                                   Km^R^, helper in triparental matings                                                                           [@b19]
  pGP1-2                                                                            Km^R^, plasmid containing gene-1 (T7 RNA polymerase)                                                                   [@b49]
  pKD3                                                                                                Ap^R^ Cm^R^ OriRγ                                                                                    [@b50]
  pKD4                                                                                                Ap^R^ Km^R^ OriRγ                                                                                    [@b50]
  pKD46                                                                              Ap^R^, *oriR101* *repA101*(ts) *araBp-gam-bet-exo*                                                                    [@b50]
  pCP20                                                                                             Ap^R^ Cm^R^ Ts (30°C)                                                                                  [@b51]
